655
Views
82
CrossRef citations to date
0
Altmetric
Original Article

The economic burden of fibromyalgia: comparative analysis with rheumatoid arthritis*

, , , , &
Pages 829-840 | Accepted 07 Jan 2009, Published online: 17 Feb 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (12)

R Isomeri, M Mikkelsson, M Partinen, H Kautiainen & MJ Kauppi. (2021) Fibromyalgia is often connected with disability pension: a very long-term follow-up study in Finland. Scandinavian Journal of Rheumatology 50:2, pages 167-168.
Read now
Neta Roitenberg & Avihu Shoshana. (2021) Physiotherapists’ accounts of fibromyalgia: role-uncertainty and professional shortcomings. Disability and Rehabilitation 43:4, pages 545-552.
Read now
Kevin Hackshaw. (2020) Assessing our approach to diagnosing Fibromyalgia. Expert Review of Molecular Diagnostics 20:12, pages 1171-1181.
Read now
Antonio Roberto Zamunér, Carolina Pieroni Andrade, Eduardo Aguilar Arca & Mariana Arias Avila. (2019) Impact of water therapy on pain management in patients with fibromyalgia: current perspectives. Journal of Pain Research 12, pages 1971-2007.
Read now
Tobias Romeyke, Elisabeth Noehammer, Hans Christoph Scheuer & Harald Stummer. (2017) Severe forms of fibromyalgia with acute exacerbation of pain: costs, comorbidities, and length of stay in inpatient care. ClinicoEconomics and Outcomes Research 9, pages 317-325.
Read now
Lyne Lalonde, Manon Choinière, Élisabeth Martin, Djamal Berbiche, Sylvie Perreault & David Lussier. (2014) Costs of moderate to severe chronic pain in primary care patients – a study of the ACCORD Program. Journal of Pain Research 7, pages 389-403.
Read now
Maya S. Santoro & Terry A. Cronan. (2013) Depression, Self-Efficacy, Health Status, and Health Care Costs: A Comparison of Men with Fibromyalgia or Osteoarthritis. Journal of Musculoskeletal Pain 21:2, pages 126-134.
Read now
Kanwaljit Chopra, Anurag Kuhad & Vipin Arora. (2011) Neoteric pharmacotherapeutic targets in fibromyalgia. Expert Opinion on Therapeutic Targets 15:11, pages 1267-1281.
Read now
Chad S Boomershine. (2010) Pregabalin for the management of fibromyalgia syndrome. Journal of Pain Research 3, pages 81-88.
Read now
Cheryl L Wright, Scott D Mist, Rebecca L Ross & Kim D Jones. (2010) Duloxetine for the treatment of fibromyalgia. Expert Review of Clinical Immunology 6:5, pages 745-756.
Read now

Articles from other publishers (70)

Yulia Treister‐Goltzman, Roni Peleg, Iftach Sagy & Idan Menashe. (2023) Health services utilization by fibromyalgia patients from two ethnic groups. International Journal of Rheumatic Diseases.
Crossref
Yulia Treister-Goltzman & Roni Peleg. (2023) Fibromyalgia and mortality: a systematic review and meta-analysis. RMD Open 9:3, pages e003005.
Crossref
Jacob N. Ablin, Erez Lang, Merav Catalogna, Valerie Aloush, Amir Hadanny, Keren Doenyas-Barak, Shachar Finci, Nir Polak, Gregory Fishlev, Calanit Korin, Rachel Yehudit Tzidky, Oshra Meir Genuth & Shai Efrati. (2023) Hyperbaric oxygen therapy compared to pharmacological intervention in fibromyalgia patients following traumatic brain injury: A randomized, controlled trial. PLOS ONE 18:3, pages e0282406.
Crossref
Martina D'Onghia, Jacopo Ciaffi, Piero Ruscitti, Paola Cipriani, Roberto Giacomelli, Jacob N. Ablin & Francesco Ursini. (2022) The economic burden of fibromyalgia: A systematic literature review. Seminars in Arthritis and Rheumatism 56, pages 152060.
Crossref
Joaquim Ivo Vasques Dantas Landim, Fábio Jennings & Diogo Souza Domiciano. (2022) Dores crônicas: fibromialgia e lombalgia. Revista Paulista de Reumatologia:2022 abr-jun;21(2), pages 91-97.
Crossref
Kishan A. Sitapara & Michelle Stern. 2022. Clinical Diagnosis in Physical Medicine & Rehabilitation. Clinical Diagnosis in Physical Medicine & Rehabilitation 101 111 .
Omer Gendelman, Raz Shapira, Shmuel Tiosano, Yuval Kuntzman, Avishai M. Tsur, Aliza Hakimian, Doron Comaneshter, Arnon D. Cohen, Dan Buskila & Howard Amital. (2021) Utilisation of healthcare services and drug consumption in fibromyalgia: A cross‐sectional analysis of the Clalit Health Service database. International Journal of Clinical Practice 75:11.
Crossref
Nadia M T Roodenrijs, Paco M J Welsing, Marlies C van der Goes, Janneke Tekstra, Floris P J G Lafeber, Johannes W G Jacobs & Jacob M van Laar. (2021) Healthcare utilization and economic burden of difficult-to-treat rheumatoid arthritis: a cost-of-illness study. Rheumatology 60:10, pages 4681-4690.
Crossref
Miao Jiang, Aimee M Near, Barnabas Desta, Xia Wang & Edward R Hammond. (2021) Disease and economic burden increase with systemic lupus erythematosus severity 1 year before and after diagnosis: a real-world cohort study, United States, 2004–2015. Lupus Science & Medicine 8:1, pages e000503.
Crossref
Yves Maugars, Jean-Marie Berthelot, Benoit Le Goff & Christelle Darrieutort-Laffite. (2021) Fibromyalgia and Associated Disorders: From Pain to Chronic Suffering, From Subjective Hypersensitivity to Hypersensitivity Syndrome. Frontiers in Medicine 8.
Crossref
Mary A. Kelley & Kevin V. Hackshaw. (2021) Intraepidermal Nerve Fiber Density as Measured by Skin Punch Biopsy as a Marker for Small Fiber Neuropathy: Application in Patients with Fibromyalgia. Diagnostics 11:3, pages 536.
Crossref
Hilary YM Pang, Chandra Farrer, Wei Wu & Natasha K Gakhal. (2021) Quality of rheumatology care for patients with fibromyalgia and chronic pain syndromes. BMJ Open Quality 10:1, pages e001061.
Crossref
Ian Gilron, Sylvia Robb, Dongsheng Tu, Ronald Holden, Tanveer Towheed, Dan Ziegler, Louie Wang, Roumen Milev & Christopher Gray. (2021) Double-blind, randomized, placebo-controlled crossover trial of alpha-lipoic acid for the treatment of fibromyalgia pain: the IMPALA trial. Pain 162:2, pages 561-568.
Crossref
Kevin V. Hackshaw. (2021) The Search for Biomarkers in Fibromyalgia. Diagnostics 11:2, pages 156.
Crossref
David A. Williams. 2021. Fibromyalgia Syndrome. Fibromyalgia Syndrome 153 172 .
A. E. Karateev & E. L. Nasonov. (2019) Chronic pain and central sensitization in immuno-inflammatory rheumatic diseases: pathogenesis, clinical manifestations, the possibility of using targeted disease modifying antirheumatic drugs. Rheumatology Science and Practice 57:2, pages 197-209.
Crossref
Frederick Wolfe, Brian Walitt, Johannes J. Rasker & Winfried Häuser. (2019) Primary and Secondary Fibromyalgia Are The Same: The Universality of Polysymptomatic Distress. The Journal of Rheumatology 46:2, pages 204-212.
Crossref
Kevin V. Hackshaw, Didem P. Aykas, Gregory T. Sigurdson, Marcal Plans, Francesca Madiai, Lianbo Yu, Charles A.T. Buffington, M. Mónica Giusti & Luis Rodriguez-Saona. (2019) Metabolic fingerprinting for diagnosis of fibromyalgia and other rheumatologic disorders. Journal of Biological Chemistry 294:7, pages 2555-2568.
Crossref
Yash S. Khandwala, Chiyuan A. Zhang & Michael L. Eisenberg. (2018) Trends in Prevalence, Management and Cost of Scrotal Pain in the United States between 2007 and 2014. Urology Practice 5:4, pages 272-278.
Crossref
Joelle Thorpe, Bonnie Shum, R Andrew Moore, Philip J Wiffen & Ian Gilron. (2018) Combination pharmacotherapy for the treatment of fibromyalgia in adults. Cochrane Database of Systematic Reviews 2020:10.
Crossref
Merih Özgen, Ayşe Merve Aydoğan, Ali Uygur, Onur Armağan, Funda Berkan & Fezan MUTLU. (2018) Fibromiyalji Sendromunda D Vitamin Düzeylerinin Değerlendirilmesi. OSMANGAZİ JOURNAL OF MEDICINE 00.
Crossref
Ian Gilron, Dongsheng Tu, Ronald Holden, Tanveer Towheed, Dan Ziegler, Louie Wang, Roumen Milev & Christopher Gray. (2017) Innovations in the Management of Musculoskeletal Pain With Alpha-Lipoic Acid (IMPALA Trial): Study protocol for a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of Alpha-Lipoic Acid for the Treatment of Fibromyalgia Pain. JMIR Research Protocols 6:3, pages e41.
Crossref
Anaïs Lacasse, Patricia Bourgault & Manon Choinière. (2016) Fibromyalgia-related costs and loss of productivity: a substantial societal burden. BMC Musculoskeletal Disorders 17:1.
Crossref
Peter W. ParkRichard D. DryerRozelle Hegeman-DingleJack MardekianGergana ZlatevaGreg G. WolffLois E. Lamerato. (2016) Cost Burden of Chronic Pain Patients in a Large Integrated Delivery System in the United States. Pain Practice 16:8, pages 1001-1011.
Crossref
Ian Gilron, Luis E. Chaparro, Dongsheng Tu, Ronald R. Holden, Roumen Milev, Tanveer Towheed, Deborah DuMerton-Shore & Sarah Walker. (2016) Combination of pregabalin with duloxetine for fibromyalgia: a randomized controlled trial. Pain 157:7, pages 1532-1540.
Crossref
Mary-Ann Fitzcharles, Peter A. Ste-Marie, Emmanouil Rampakakis, John S. Sampalis & Yoram Shir. (2016) Disability in Fibromyalgia Associates with Symptom Severity and Occupation Characteristics. The Journal of Rheumatology 43:5, pages 931-936.
Crossref
Yvonne van Eijk-Hustings, Mariëlle Kroese, An Creemers, Robert Landewé & Annelies Boonen. (2015) Resource utilisation and direct costs in patients with recently diagnosed fibromyalgia who are offered one of three different interventions in a randomised pragmatic trial. Clinical Rheumatology 35:5, pages 1307-1315.
Crossref
Yasser El Miedany, Maha El Gaafary, Sally Youssef & Ihab Ahmed. (2016) Towards Tailored Patient’s Management Approach: Integrating the Modified 2010 ACR Criteria for Fibromyalgia in Multidimensional Patient Reported Outcome Measures Questionnaire. Arthritis 2016, pages 1-9.
Crossref
Kimberley Lee, Malcolm H Johnson, Julie Harris & Frederick Sundram. (2016) The resource utilisation of medically unexplained physical symptoms. SAGE Open Medicine 4, pages 205031211666621.
Crossref
Christine Cedraschi, Elodie Girard, Valérie Piguet, Jules Desmeules & Anne-Françoise Allaz. (2015) Assessing the affective load in the narratives of women suffering from fibromyalgia: the clinicians' appraisal. Health Expectations 18:6, pages 3325-3335.
Crossref
Banafsheh Ghavidel-Parsa, Ali Bidari, Alireza Amir Maafi & Babak Ghalebaghi. (2015) The Iceberg Nature of Fibromyalgia Burden: The Clinical and Economic Aspects. The Korean Journal of Pain 28:3, pages 169-176.
Crossref
Kate L. Lapane, Brian J. Quilliam, Carmela Benson, Wing Chow & Myoung S. Kim. (2015) Impact of Noncancer Pain on Health-Related Quality of Life. Pain Practice 15:4, pages 333-342.
Crossref
Kirstine Amris, Eva E. Wæhrens, Robin Christensen, Henning Bliddal & Bente Danneskiold-Samsøe. (2014) Interdisciplinary rehabilitation of patients with chronic widespread pain: Primary endpoint of the randomized, nonblinded, parallel-group IMPROvE trial. Pain 155:7, pages 1356-1364.
Crossref
Tracy L. Skaer. (2014) Fibromyalgia: Disease Synopsis, Medication Cost Effectiveness and Economic Burden. PharmacoEconomics 32:5, pages 457-466.
Crossref
Stephen S. Johnston, Margarita Udall, Jose Alvir, Donna McMorrow, Robert Fowler & Daniel Mullins. (2014) Characteristics, Treatment, and Health Care Expenditures of Medicare Supplemental-Insured Patients with Painful Diabetic Peripheral Neuropathy, Post-Herpetic Neuralgia, or Fibromyalgia. Pain Medicine 15:4, pages 562-576.
Crossref
Akiko Okifuji & Bradford D. Hare. 2014. Handbook of Musculoskeletal Pain and Disability Disorders in the Workplace. Handbook of Musculoskeletal Pain and Disability Disorders in the Workplace 101 120 .
Patricia Clark, Eduardo S Paiva, Anna Ginovker & Patricia Arline Salomón. (2013) A patient and physician survey of fibromyalgia across Latin America and Europe. BMC Musculoskeletal Disorders 14:1.
Crossref
Cecilia P. Chung, Patricia Rohan, Shanthi Krishnaswami & Melissa L. McPheeters. (2013) A systematic review of validated methods for identifying patients with rheumatoid arthritis using administrative or claims data. Vaccine 31, pages K41-K61.
Crossref
Siva Narayanan, Kathleen Wilson, Alan Ogelsby, Paul Juneau & Emily Durden. (2013) Economic Burden of Systemic Lupus Erythematosus Flares and Comorbidities in a Commercially Insured Population in the United States. Journal of Occupational & Environmental Medicine 55:11, pages 1262-1270.
Crossref
Stephen S. Johnston, Adam Turpcu, Nianwen Shi, Robert Fowler, Bong-Chul Chu & Kimberly Alexander. (2013) Risk of infections in rheumatoid arthritis patients switching from anti-TNF agents to rituximab, abatacept, or another anti-TNF agent, a retrospective administrative claims analysis. Seminars in Arthritis and Rheumatism 43:1, pages 39-47.
Crossref
Ian Gilron, Bonnie Shum, R Andrew Moore & Philip J Wiffen. (2013) Combination pharmacotherapy for the treatment of fibromyalgia. Cochrane Database of Systematic Reviews.
Crossref
Maria Goutsou, Ozgecan Uluscu, Angela Amend Kwasnik, Robert Stianchi, Paul M Peloso & Gillian Cannon. (2013) Biologics utilization for rheumatoid arthritis in the United States: An observational longitudinal study. Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing 13:2, pages 74-81.
Crossref
DE Furst, A Clarke, AW Fernandes, T Bancroft, K Gajria, W Greth & SR Iorga. (2013) Resource utilization and direct medical costs in adult systemic lupus erythematosus patients from a commercially insured population. Lupus 22:3, pages 268-278.
Crossref
Nathan L. Kleinman, Mary A. Cifaldi, James E. Smeeding, James W. Shaw & Richard A. Brook. (2013) Annual Incremental Health Benefit Costs and Absenteeism Among Employees With and Without Rheumatoid Arthritis. Journal of Occupational & Environmental Medicine 55:3, pages 240-244.
Crossref
Kevin V. Hackshaw, Luis Rodriguez-Saona, Marçal Plans, Lauren N. Bell & C. A. Tony Buffington. (2013) A bloodspot-based diagnostic test for fibromyalgia syndrome and related disorders. The Analyst 138:16, pages 4453.
Crossref
DANIEL E. FURST, ANCILLA W. FERNANDES, SERBAN R. IORGA, WARREN GRETH & TIM BANCROFT. (2012) Annual Medical Costs and Healthcare Resource Use in Patients with Systemic Sclerosis in an Insured Population. The Journal of Rheumatology 39:12, pages 2303-2309.
Crossref
Jan-Samuel Wagner, Marco D DiBonaventura, Arthi B Chandran & Joseph C Cappelleri. (2012) The association of sleep difficulties with health-related quality of life among patients with fibromyalgia. BMC Musculoskeletal Disorders 13:1.
Crossref
Urban Schwegler, Jessica Anner, Christine Boldt, Andrea Glässel, Veronika Lay, Wout Ernst Lodewijk De Boer, Gerold Stucki & Bruno Trezzini. (2012) Aspects of functioning and environmental factors in medical work capacity evaluations of persons with chronic widespread pain and low back pain can be represented by a combination of applicable ICF Core Sets. BMC Public Health 12:1.
Crossref
Bill H. McCarberg. (2012) Clinical Overview of Fibromyalgia. American Journal of Therapeutics 19:5, pages 357-368.
Crossref
Lesley M. Arnold, Daniel J. Clauw, L. Jean Dunegan & Dennis C. Turk. (2012) A Framework for Fibromyalgia Management for Primary Care Providers. Mayo Clinic Proceedings 87:5, pages 488-496.
Crossref
E. R. Bossema, M. B. Kool, D. Cornet, P. Vermaas, M. de Jong, H. van Middendorp & R. Geenen. (2011) Characteristics of suitable work from the perspective of patients with fibromyalgia. Rheumatology 51:2, pages 311-318.
Crossref
James P. Burke, Robert J. Sanchez, Ashish V. Joshi, Joseph C. Cappelleri, Mahesh Kulakodlu & Rachel Halpern. (2011) Health Care Costs in Patients with Fibromyalgia on Pregabalin vs. Duloxetine. Pain Practice 12:1, pages 14-22.
Crossref
Sheeva M. Mostoufi, Niloofar Afari, Sandra M. Ahumada, Veronica Reis & Julie Loebach Wetherell. (2012) Health and distress predictors of heart rate variability in fibromyalgia and other forms of chronic pain. Journal of Psychosomatic Research 72:1, pages 39-44.
Crossref
C. Littlejohn, D. Pang, C. Power, G.J. Macfarlane & G.T. Jones. (2012) Is there an association between preterm birth or low birthweight and chronic widespread pain? Results from the 1958 Birth Cohort Study. European Journal of Pain 16:1, pages 134-139.
Crossref
Benjamin P. Linas, Angela Y. Wong, Kenneth A. Freedberg & C. Robert HorsburghJr.Jr.. (2011) Priorities for Screening and Treatment of Latent Tuberculosis Infection in the United States. American Journal of Respiratory and Critical Care Medicine 184:5, pages 590-601.
Crossref
Francis Creed, Arthur Barsky & Kari Ann Leiknes. 2011. Medically Unexplained Symptoms, Somatisation and Bodily Distress. Medically Unexplained Symptoms, Somatisation and Bodily Distress 1 42 .
MARIËLLE E. KROESE, JOHAN L. SEVERENS, GUY J. SCHULPEN, MONIQUE C. BESSEMS, FRANS J. NIJHUIS & ROBERT B. LANDEWÉ. (2011) Specialized Rheumatology Nurse Substitutes for Rheumatologists in the Diagnostic Process of Fibromyalgia: A Cost-Consequence Analysis and a Randomized Controlled Trial. The Journal of Rheumatology 38:7, pages 1413-1422.
Crossref
Margaret McDonald, Marco daCosta DiBonaventura & Stacey Ullman. (2011) Musculoskeletal Pain in the Workforce. Journal of Occupational & Environmental Medicine 53:7, pages 765-770.
Crossref
Fausto Salaffi, Piercarlo Sarzi-Puttini, Alessandro Ciapetti & Fabiola Atzeni. (2011) Clinimetric evaluations of patients with chronic widespread pain. Best Practice & Research Clinical Rheumatology 25:2, pages 249-270.
Crossref
Kristin Sauer, Claudia Kemper & Gerd Glaeske. (2011) Prévalence et prise en charge thérapeutique ambulatoire, pharmacologique et non pharmacologique, de la fibromyalgie. Une analyse des données provenant d’une caisse publique d’assurance maladie. Revue du Rhumatisme 78:1, pages 63-68.
Crossref
Kristin Sauer, Claudia Kemper & Gerd Glaeske. (2011) Fibromyalgia syndrome: Prevalence, pharmacological and non-pharmacological interventions in outpatient health care. An analysis of statutory health insurance data. Joint Bone Spine 78:1, pages 80-84.
Crossref
Atul Deodhar & Dawn A. MarcusDawn A. Marcus & Atul Deodhar. 2011. Fibromyalgia. Fibromyalgia 9 21 .
Stuart L. Silverman, James Harnett, Gergana Zlateva & Jack Mardekian. (2010) Identifying Fibromyalgia-Associated Symptoms and Conditions from a Clinical Perspective: A Step Toward Evaluating Healthcare Resource Utilization in Fibromyalgia. Pain Practice 10:6, pages 520-529.
Crossref
Peter Przekop, Mark G. Haviland, Kelly R. Morton, Keiji Oda & Gary E. Fraser. (2010) Correlates of Perceived Pain-Related Restrictions among Women with Fibromyalgia. Pain Medicine 11:11, pages 1698-1706.
Crossref
Lene Dreyer, Sally Kendall, Bente Danneskiold‐Samsøe, Else Marie Bartels & Henning Bliddal. (2010) Mortality in a cohort of Danish patients with fibromyalgia: Increased frequency of suicide. Arthritis & Rheumatism 62:10, pages 3101-3108.
Crossref
Chad S. Boomershine. (2010) The FIBRO System: a rapid strategy for assessment and management of fibromyalgia syndrome. Therapeutic Advances in Musculoskeletal Disease 2:4, pages 187-200.
Crossref
Robert H. PalmerAntonia Periclou & Pradeep Banerjee. (2010) Milnacipran: a selective serotonin and norepinephrine dual reuptake inhibitor for the management of fibromyalgia. Therapeutic Advances in Musculoskeletal Disease 2:4, pages 201-220.
Crossref
Daniel J. Cameron. (2010) Proof That Chronic Lyme Disease Exists. Interdisciplinary Perspectives on Infectious Diseases 2010, pages 1-4.
Crossref
Nathan Kleinman, James Harnett, Arthur Melkonian, Wendy Lynch, Barbara Kaplan-Machlis & Stuart L. Silverman. (2009) Burden of Fibromyalgia and Comparisons With Osteoarthritis in the Workforce. Journal of Occupational & Environmental Medicine 51:12, pages 1384-1393.
Crossref
Carlomaurizio Montecucco, Lorenzo Cavagna & Roberto Caporali. (2009) Pain and rheumatology: An overview of the problem. European Journal of Pain Supplements 3:S2, pages 105-109.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.